Ticker Scorecard - TNXP Basics Company: Tonix Pharmaceuticals Holding Corp. IPO Date: June 1, 2012 Sector: Healthcare Industry: Biotech Market Cap: $51.26M Activated in VL: True Average Daily Range Avg Daily Range: $0.13 | 4.37% Avg Daily Range (30 D): $0.36 | 8.62% Avg Daily Range (90 D): $0.19 | 10.37% Institutional Daily Volume Avg Daily Volume: .04M Avg Daily Volume (30 D): 1.3M Avg Daily Volume (90 D): 1.04M Trade Size Avg Trade Size (Sh.): 4 Avg Trade Size (Sh.) (30 D): 23 Avg Trade Size (Sh.) (90 D): 16 Institutional Trades Total Inst.Trades: 91 Avg Inst. Trade: $1.71M Avg Inst. Trade (30 D): $.7M Avg Inst. Trade (90 D): $1.51M Avg Inst. Trade Volume: M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.9M Avg Closing Trade (30 D): $3.88M Avg Closing Trade (90 D): $3.88M Avg Closing Volume: 3.18K     News Feb 5, 2025 @ 12:00 PM Tonix Pharmaceuticals to Participate in the 2025 B... Source: N/A Nov 26, 2024 @ 12:00 PM Tonix Pharmaceuticals to Participate in the NobleC... Source: Globe Newswire Nov 1, 2024 @ 11:00 AM Tonix Pharmaceuticals Presented Data on Potential ... Source: N/A Oct 29, 2024 @ 12:00 PM Tonix Pharmaceuticals to Present at BIO-Europe®... Source: N/A Sep 27, 2024 @ 11:00 AM Tonix Pharmaceuticals Announces Issuance of U.S. P... Source: N/A Financials   TTM Q3 2024 Q2 2024 Basic EPS $109.06 $-.23 $-19.28 Diluted EPS $109.06 $-.23 $-19.28 Revenue $ 11.29M $ 2.82M $ 2.21M Gross Profit $ $ 1.27M $ Net Income / Loss $ -135.25M $ -14.21M $ -78.78M Operating Income / Loss $ -141.55M $ -15.55M $ -77.32M Cost of Revenue $ $ 1.56M $ Net Cash Flow $ 21.22M $ 24.08M $ -2.89M PE Ratio 0.09     Splits Feb 05, 2025:   100:1 Jun 10, 2024:   32:1 May 10, 2023:   25:4 May 17, 2022:   32:1 Nov 01, 2019:   10:1 Nov 28, 2018:   10:1 Mar 17, 2017:   10:1 May 01, 2013:   20:1